Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma

Abstract

Histology slides and patients' clinicodemographic characteristics are readily available through standard of care and have the potential to predict ICI treatment outcomes. With prospective validation, we believe our approach has potential for integration into clinical practice.